PROCEPT BioRobotics Lowers FY2026 Sales Guidance from $410.000M-$430.000M to $390.000M-$410.000M
Benzinga Newsdesk 8 months ago
NewsGuidance
PROCEPT BioRobotics (NASDAQ:PRCT) lowers FY2026 sales outlook from $410.000 million-$430.000 million to $390.000 million-$410.000 million.
PROCEPT BioRobotics (NASDAQ:PRCT) lowers FY2026 sales outlook from $410.000 million-$430.000 million to $390.000 million-$410.000 million.